SurvivorNet

SurvivorNet

https://www.survivornet.com
https://www.linkedin.com/company/survivornetmedia/

SurvivorNet, a privately owned company headquartered in the US, was founded in 2017 and operates with approximately 20 employees. The company reported $13.2M in revenue as of 2023 and is classified as a tier 2 media tech buyer. Functioning as a digital media company, SurvivorNet specializes in providing information about cancer through its media and TV services.

Revenue

Founded

2017

Headcount

19

Headquarters

US

Primary Segment

Media and TV services

Ownership

Privately Owned

News Summary:

On March 16, 2026, SurvivorNet highlighted a new wave of cancer patients using its "My Health AI Tools," particularly "My Health Questions," for support in navigating their care. Breast cancer survivor Christine Santasiero described the early stages of cancer care as overwhelming, akin to learning "a completely new language" due to complex medications, side effects, and terminology. This followed a March 11, 2026, report where SurvivorNet emphasized its role as a doctor-supported AI source for cancer patients seeking reliable healthcare information amidst the challenges of processing complex medical details. Earlier, on January 6, 2026, Al Roker announced a collaboration with SurvivorNet on a new docuseries. In this project, Roker engaged with fellow prostate cancer survivors, discussing their experiences, misconceptions, and challenges to address and combat the stigma associated with prostate cancer.

Similar Companies

Subscribe for full access to SurvivorNet's profile

SurvivorNet offers products in the media and telecoms services industry. SurvivorNet's product portfolio comprises of media and TV services.

Subscribe for full access to SurvivorNet's products in full detail

SurvivorNet's revenues were less than $25M in 2023. All the revenue comes from video streaming.

Subscribe for full access to SurvivorNet's revenue in full detail

Mar

25th

2026

20:51

‘Survival and Suffering Are Not Mutually Exclusive’: Study Finds Women Cancer Patients Live Longer Than Men With Cancer, But Face Tougher Side Effects

“Women have a 21% lower risk of death than men, yet they experience a 12% higher risk of severe treatment toxicities. Survival and suffering are not mutually exclusive,” Dr. Worster further explains to SurvivorNet. Experts speaking with SurvivorNet surmise that the study should provide added encouragement for women to push for meaningful side-effect management as part of their overall treatment plan.

Mar

23rd

2026

13:13

Emerging Tech, B2B Tag

AI‑Powered Tool Helps Man Battling Prostate Cancer Navigate Worrying Symptoms & Next Steps In Treatment

“The first time I heard the word cancer in relation to my own health, I was devastated,” Dr. Franklin tells SurvivorNet. “I’d lived my whole life being active, working out, doing everything right. How could I possibly have a high PSA number?” Like many people in the confusing early days of a diagnosis, he found himself searching for clarity between appointments.

Mar

16th

2026

16:38

Artificial Intelligence, B2B Tag

Critical Questions. Trusted Answers. A New Wave of Cancer Patients Using SurvivorNet’s My Health AI Tools For Support

WATCH: How One Cancer Survivor and Her Sister Used “My Health Questions” to Navigate Care For many patients, the experience of cancer care is overwhelming, particularly in the early stages when appointments can feel rushed, and information is difficult to process.

Mar

16th

2026

16:38

Artificial Intelligence, B2B Tag

Critical Questions. Trusted Answers. A New Wave of Cancer Patients Using SurvivorNet’s My Health AI Tools For Support

For many patients, the experience of cancer care is overwhelming, particularly in the early stages when appointments can feel rushed, and information is difficult to process. As breast cancer survivor Christine Santasiero describes, the experience can feel like learning “a completely new language,” with medications, side effects, and terminology that are difficult to process in real time.

Mar

11th

2026

14:50

Artificial Intelligence, B2B Tag

As More People Turn to AI for Healthcare Answers, Cancer Patients Get a Doctor-Supported Source They Can Trust

For many patients, the experience of cancer care is overwhelming, particularly in the early stages when appointments can feel rushed, and information is difficult to process. As breast cancer survivor Christine Santasiero describes, the experience can feel like learning “a completely new language,” with medications, side effects, and terminology that are difficult to process in real time.

Jan

6th

2026

08:58

Al Roker Talks New Docuseries With Prostate Cancer Survivors

TODAY's Al Roker opens up about his new project with Survivornet where he sits down with fellow prostate cancer survivors who share the experiences, misconceptions, and challenges they’ve faced in an effort to combat the stigma that continues to surround prostate cancer.Jan.

Jan

4th

2026

00:36

Former First Lady Recovering From Hormone Therapy For Breast Cancer Treatment Says Despite Side Effects, She’s ‘Grateful,’ Urges Other Women to Get Yearly Screening

France’s former first lady Carla Bruni, 58, is marking a major milestone in her breast cancer journey: completing five years of hormone therapy. She acknowledges that the treatment can be challenging—its side effects often mirror the symptoms of menopause—but she emphasizes its powerful long-term protection.

Dec

7th

2025

20:30

‘That Mammogram Saved My Life’: A Busy Mom of Two Says She Missed Her Mammogram Appt, and When She Got the Courage to Reschedule, She Learned She Had Triple-Negative Breast Cancer, an Aggressive Form

Rachel Albin, a Missouri mother of two, says her family’s world was turned upside down after she missed a routine mammogram and later learned she had triple-negative breast cancer—one of the most aggressive forms of the disease.

Aug

27th

2025

23:15

Events, CT_Monitor Company

Key Information For Patients To Evaluate Prostate Cancer Treatment Options: Stage & Type Matter

Every prostate cancer journey begins with a clear understanding of the diagnosis. This isn’t a “one-size-fits-all” disease, and treatment plans are highly personalized. “When we’re evaluating a case for treatment options, the first thing is determine the stage,” Dr. Edward Yen, medical oncologist at Baylor College of Medicine in Houston, tells SurvivorNet.

Jul

2nd

2025

11:54

New Offerings, Regulatory and Legal,

New Hope for Patients With Advanced Lung Cancer: Datroway, A New FDA Approval

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. “This approval is especially important for patients whose cancer has progressed after previous treatment or who could not tolerate earlier therapies,” Dr. Fatemeh Ardeshir, thoracic oncologist at Winship Cancer Institute of Emory University, tells SurvivorNet.

Jul

1st

2025

18:30

New Offerings, Regulatory and Legal,

New Hope for Patients With Advanced Lung Cancer: Datroway, A New FDA Approval

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. “This approval is especially important for patients whose cancer has progressed after previous treatment or who could not tolerate earlier therapies,” Dr. Fatemeh Ardeshir, thoracic oncologist at Winship Cancer Institute of Emory University, tells SurvivorNet.

Jun

24th

2025

18:14

Operational Challenges,

A Targeted Strike: How Radioligand Therapy Finds And Fights Advanced Prostate Cancer

Radioligand therapy, such as Pluvicto, delivers targeted radiation to prostate cancer cells by binding to PSMA, a protein commonly found on these cells, while minimizing damage to healthy tissue. “Radioligand therapy is the use of IV treatments that contain a molecule that seeks out a particular target, somewhere in your body, and then once it latches onto that target, releases a dose of radiation,” Dr. Janaki Sharma, a medical oncologist at the University of Miami Cancer Center, tells SurvivorNet.

Examples of SurvivorNet's suppliers include JWX and Backlight.

Example Suppliers

Subscribe for full access to SurvivorNet's profile

Analyst insight reports

Build or buy in video streaming

What a winning pay TV architecture looks like

How digital signage, retail media and programmatic are fueling the DOOH growth

Retaining subscribers beyond 2025

Subscribe to access all analyst insight reports